Intravitreal high dose ( 2 mg ) ranibizumab may lead to quicker resolution of choroidal neovascularization ( CNV ) and associated retinal pigment epithelial detachment in eyes with exudative age-related macular degeneration , although it may possibly correlate with RPE tears in certain cases .